Dual‐Stage Light Amplified Photodynamic Therapy against Hypoxic Tumor Based on an O2 Self‐Sufficient Nanoplatform
Abstract
Tumor hypoxia severely limits the efficacy of traditional photodynamic therapy (PDT). Here, a liposome‐based nanoparticle (designated as LipoMB/CaO2) with O2 self‐sufficient property for dual‐stage light‐driven PDT is demonstrated to address this problem. Through a short time irradiation, 1O2 activated by the photosensitizer methylene blue (MB) can induce lipid peroxidation to break the liposome, and enlarge the contact area of CaO2 with H2O, resulting in accelerated O2 production. Accelerated O2 level further regulates hypoxic tumor microenvironment and in turn improves 1O2 generation by MB under another long time irradiation. In vitro and in vivo experiments also demonstrate the superior competence of LipoMB/CaO2 to alleviate tumor hypoxia, suppress tumor growth and antitumor metastasis with low side‐effect. The O2 self‐sufficient LipoMB/CaO2 nanoplatform with dual‐stage light manipulation is a successful attempt for PDT against hypoxic tumor.Keywords
Funding Information
- National Natural Science Foundation of China (51233003, 51690152)
This publication has 41 references indexed in Scilit:
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- Hyperbaric oxygen therapy and cancer—a reviewTargeted Oncology, 2012
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapyTrends in Pharmacological Sciences, 2012
- Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterialsProceedings of the National Academy of Sciences, 2012
- Cell Death Pathways in Photodynamic Therapy of CancerCancers, 2011
- Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy¶Photochemistry and Photobiology, 2007
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Enzyme entrapment in liposomesFEBS Letters, 1971